Back

Outcomes of sutureless aortic valve replacement (SU-AVR) in moderate-to-high risk patients with unexplained postoperative thrombocytopenia

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Valvular heart disease (diagnosis, management and interventional therapies) Valvular heart disease HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

9 More presentations in this session

Presentation thumbnail
Left ventricular mechanics in mitral valve prolapse
Professor J. Trochu (Nantes, FR)
Abstract
Presentation thumbnail
Percutaneous mitral balloon valvotomy. echocardiographic score, risk factors for death and major events in long-term follow-up.
Professor I. Borges de Aragao (Rio de Janeiro, BR)
Abstract Slides
Presentation thumbnail
Long-term evaluation of the Ross procedure: clinical and echocardiographic follow-up at 20 years
Doctor S. Guerreiro (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Indexed device landing zone calcium volume predicts moderate/severe aortic regurgitation after tavi with 1st and 2nd generation self-expandable prosthesis
Doctor S. Moura Ferreira (Hasselt, BE)
Abstract
Presentation thumbnail
The improvement of right ventricular function in heart failure patients following percutaneous mitral valve repair using MitraClip system

Access the full session

Session thumbnail
Poster Session 2 - Valvular heart disease (diagnosis, management and interventional therapies)

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources